Clinical Study of Magnetic Resonance Imaging and Deep Learning of Joint Synovial Disease

NCT ID: NCT04952896

Last Updated: 2022-11-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

350 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-01-01

Study Completion Date

2022-10-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Through the high-throughput feature extraction of magnetic resonance images, the deep learning prediction model of joint synovial lesions is constructed used for the diagnosis, differential diagnosis and curative effect monitoring of joint synovial lesions.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study applies magnetic resonance and deep learning (DL) to the diagnosis of joint synovial lesions, aims to have a more comprehensive understanding of the pathophysiology of the occurrence and development of joint synovial lesions. As a non-invasive imaging method to assess the condition of the disease, DL methods excavates the deep features contained in the image, quantifies the joint synovial lesions, and then gives more information to the clinician in the diagnosis and differential diagnosis of the joint synovial lesions, provide important information for the planning of individualized treatment plans for patients with joint synovial diseases.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Synovial Diseases Pigmented Villonodular Synovitis Gout Rheumatoid Arthritis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group of patients with pigmented villonodular synovitis

Diagnosis confirmed by arthroscopic pathological biopsy.

Synovitis diagnosis

Intervention Type DIAGNOSTIC_TEST

Group of patients with rheumatoid arthritis

Diagnosis determined by clinical history, laboratory tests and arthroscopic pathology biopsy.

Synovitis diagnosis

Intervention Type DIAGNOSTIC_TEST

Group of patients with gout

Diagnosis was determined by laboratory tests, energy spectrum imaging and arthroscopic pathology biopsy.

Synovitis diagnosis

Intervention Type DIAGNOSTIC_TEST

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Synovitis diagnosis

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patients diagnosed with joint synovial disease through radiological examination, arthroscopy or pathological biopsy of the joint, or whose clinical manifestations meet the diagnostic criteria of the American College of Rheumatology (ACR) for joint synovial disease.
2. Patients received pre-treatment MR.

Exclusion Criteria

1. Patients who have received surgery, medication or other systemic treatment before standardized MRI scan.
2. Poor image quality.
3. Articular hemorrhage.
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Peking University Third Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Peking University third hospital

Beijing, Please Select An Option Below, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

LM2019168

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

CMR-AI and Outcomes in AS
NCT06128876 ACTIVE_NOT_RECRUITING
Deep Learning CAD Screening on Chest CT
NCT07181512 NOT_YET_RECRUITING